| Previous Close | 65.26 |
| Open | 65.00 |
| Bid | 65.23 x 300 |
| Ask | 65.67 x 400 |
| Day's Range | 64.01 - 65.67 |
| 52 Week Range | 40.58 - 69.53 |
| Volume | 66,990 |
| Avg. Volume | 286,657 |
| Market Cap | 2.5B |
| Beta | 3.31 |
| PE Ratio (TTM) | -16.08 |
| EPS (TTM) | -4.07 |
| Earnings Date | Oct 30, 2017 - Nov 3, 2017 |
| Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 78.46 |
- GlobeNewswire•3 days ago
Prothena Presents New Research Supporting Clinical Relevance of Cardiac Biomarker NT-proBNP in AL Amyloidosis
Preclinical Research Demonstrating a Direct Relationship Between Misfolded Light Chain Toxicity and NT-proBNP Production Clinical Outcomes Research Showing a Correlation between NT-proBNP Response and ...
- Investor's Business Daily•3 days ago
Stocks Flashing Renewed Technical Strength: Prothena
A Relative Strength Rating upgrade for Prothena shows improving technical performance.
- Capital Cube•8 days ago
ETFs with exposure to Prothena Corp. Plc : September 13, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Prothena Corp. Plc Here are 5 ETFs with the largest exposure to PRTA-US. Comparing the performance and risk of Prothena Corp. Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)
